These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22890312)

  • 21. ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis.
    Urushihara M; Takamatsu M; Shimizu M; Kondo S; Kinoshita Y; Suga K; Kitamura A; Matsuura S; Yoshizumi M; Tamaki T; Kawachi H; Kagami S
    Am J Physiol Renal Physiol; 2010 Jan; 298(1):F167-76. PubMed ID: 19846573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
    Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
    Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of collagen gel contraction by angiotensin II and III in cardiac fibroblasts.
    Lijnen P; Petrov V; Rumilla K; Fagard R
    J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):160-6. PubMed ID: 12563566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
    Takai S; Kirimura K; Jin D; Muramatsu M; Yoshikawa K; Mino Y; Miyazaki M
    Hypertens Res; 2005 Jul; 28(7):593-600. PubMed ID: 16335888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties.
    Zanchi A; Dulloo AG; Perregaux C; Montani JP; Burnier M
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E91-5. PubMed ID: 17374699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
    Harada N; Shimozawa N; Okajima K
    Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.
    Aubert G; Burnier M; Dulloo A; Perregaux C; Mazzolai L; Pralong F; Zanchi A
    Metabolism; 2010 Jan; 59(1):25-32. PubMed ID: 19793594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of angiotensin II receptor antagonist telmisartan on detrusor overactivity in rats with bladder outlet obstruction.
    Cho ST; Park EY; Kim JC
    Urology; 2012 Nov; 80(5):1163.e1-7. PubMed ID: 22795377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.
    Hasegawa G; Fukui M; Hosoda H; Asano M; Harusato I; Tanaka M; Shiraishi E; Senmaru T; Sakabe K; Yamasaki M; Kitawaki J; Fujinami A; Ohta M; Obayashi H; Nakamura N
    Eur J Pharmacol; 2009 Mar; 605(1-3):164-9. PubMed ID: 19171132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodynamic and pulse wave responses to intravenous infusions of angiotensin II during chronic telmisartan therapy in normal volunteers.
    Vingerhoedt NM; Gilles R; Howes JB; Griffin M; Howes LG
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):244-8. PubMed ID: 14689372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
    Clemenz M; Frost N; Schupp M; Caron S; Foryst-Ludwig A; Böhm C; Hartge M; Gust R; Staels B; Unger T; Kintscher U
    Diabetes; 2008 May; 57(5):1405-13. PubMed ID: 18184928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WB1106, a novel nitric oxide-releasing derivative of telmisartan, inhibits hypertension and improves glucose metabolism in rats.
    Li YQ; Ji H; Zhang YH; Shi WB; Meng ZK; Chen XY; Du GT; Tian J
    Eur J Pharmacol; 2007 Dec; 577(1-3):100-8. PubMed ID: 17822696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different roles of PPAR-γ activity on physiological and pathological alteration after myocardial ischemia.
    Nagashima A; Watanabe R; Ogawa M; Suzuki J; Masumura M; Hishikari K; Shimizu T; Takayama K; Hirata Y; Nagai R; Isobe M
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):158-64. PubMed ID: 22561360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
    Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
    Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.
    Nakamura K; Yamagishi S; Nakamura Y; Takenaka K; Matsui T; Jinnouchi Y; Imaizumi T
    Microvasc Res; 2005 Nov; 70(3):137-41. PubMed ID: 16271939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of different NADPH oxidase homologues with late endothelial progenitor cell senescence induced by angiotensin II: effect of telmisartan.
    Li H; Liu Q; Wang N; Xu J
    Intern Med; 2011; 50(16):1631-42. PubMed ID: 21841319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
    Kakuta H; Sudoh K; Sasamata M; Yamagishi S
    Int J Clin Pharmacol Res; 2005; 25(1):41-6. PubMed ID: 15864875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
    Toba H; Tojo C; Wang J; Noda K; Kobara M; Nakata T
    Eur J Pharmacol; 2012 Jun; 685(1-3):91-8. PubMed ID: 22314223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of telmisartan on angiotensin II-mediated collagen gel contraction by adult rat cardiac fibroblasts.
    Lijnen PJ; Petrov VV; Jackson KC; Fagard RH
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):39-48. PubMed ID: 11444501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.